Impact Ethics

Disclaimer
Submit A Post
About
The Body Economy

Making a Difference in Bioethics

Tag Archives: Deborah Gleeson

Monopolies on New Medicines & Trade with the U.S.

November 14, 2018 · by impact ethics · in Pharmaceuticals, Public Health, Science and Technology

Deborah Gleeson and Ronald Labonté object to lengthening market exclusivity for biologic medicines in the United States-Mexico-Canada Agreement.

Learn about The Body Economy

Read Impact Ethics posts on The Body Economy

Watch: The Body Economy: Human Eggs in the Marketplace

Watch: The Body Economy: Surrogacy in the Marketplace

Watch: The Body Economy: Blood products in the Marketplace

Watch: The Body Economy: Breast milk in the Marketplace

Watch: The Body Economy: Organs in the Marketplace

Follow us on Twitter

Subscribe by email

Email Address:

Topics

Subscribe by RSS Feed

Bioethics Forum

Mark Cuban’s Innovative Pharmacy: A Band-Aid on Drug Prices

Biopolitical Times

"It is a basic right of every human being to know where they come from."

Fear & Loathing in Bioethics

"Ninety percent of what I made went to women, whiskey, drugs and cars,” he said. “I guess I just wasted the other 10 percent.”

Healthy Debate

Gallery’s ‘at-home apothecary’ exhibit holds a critical lens to the wellness industry

Practical Ethics

First synthetic embryos: the scientific breakthrough raises serious ethical questions

Archives

Blog at WordPress.com.

Follow Following
- Impact Ethics
- Already have a WordPress.com account? Log in now.